Citadel Advisors
CLOV icon

Citadel Advisors’s Clover Health Investments CLOV Stock Holding History

Citadel Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Sell
1,017,800
-295,200
-22% -$640K ﹤0.01% 6314
2025
Q4 		$3.09M Buy
1,313,000
+192,000
+17% +$525K ﹤0.01% 5103
2025
Q3 		$3.43M Buy
1,121,000
+174,600
+18% +$499K ﹤0.01% 5056
2025
Q2 		$2.64M Sell
946,400
-39,800
-4% -$131K ﹤0.01% 5187
2025
Q1 		$3.54M Buy
986,200
+220,600
+29% +$886K ﹤0.01% 4478
2024
Q4 		$2.41M Sell
765,600
-218,100
-22% -$779K ﹤0.01% 5244
2024
Q3 		$2.77M Buy
983,700
+398,600
+68% +$912K ﹤0.01% 4933
2024
Q2 		$720K Buy
585,100
+60,900
+12% +$54.7K ﹤0.01% 7308
2024
Q1 		$416K Buy
524,200
+83,800
+19% +$76.3K ﹤0.01% 8783
2023
Q4 		$419K Buy
440,400
+48,900
+12% +$48K ﹤0.01% 8476
2023
Q3 		$423K Buy
391,500
+95,900
+32% +$114K ﹤0.01% 8431
2023
Q2 		$265K Sell
295,600
-137,700
-32% -$122K ﹤0.01% 9309
2023
Q1 		$366K Sell
433,300
-396,400
-48% -$434K ﹤0.01% 8965
2022
Q4 		$771K Buy
829,700
+351,200
+73% +$469K ﹤0.01% 7339
2022
Q3 		$813K Sell
478,500
-4,900
-1% -$12.8K ﹤0.01% 7438
2022
Q2 		$1.03M Sell
483,400
-1,168,300
-71% -$3.1M ﹤0.01% 6940
2022
Q1 		$5.86M Buy
1,651,700
+1,141,000
+223% +$3.31M ﹤0.01% 3869
2021
Q4 		$1.9M Sell
510,700
-598,000
-54% -$3.67M ﹤0.01% 6369
2021
Q3 		$8.19M Sell
1,108,700
-644,500
-37% -$5.51M ﹤0.01% 3419
2021
Q2 		$23.4M Buy
1,753,200
+1,324,200
+309% +$13M 0.01% 1897
2021
Q1 		$3.24M Buy
429,000
+36,500
+9% +$412K ﹤0.01% 5251
2020
Q4 		$6.58M Buy
+392,500
New +$4.37M ﹤0.01% 3218

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's CLOV Position: Q1 2026 in Review

Citadel Advisors increased its Clover Health Investments (CLOV) stake by 64% in Q1 2026, buying an estimated $1.58M and bringing the position to 1,878,048 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5074.

Citadel Advisors first reported a position in CLOV in Q4 2020 and has held it in 22 quarters since. The position peaked at $13.4M in Q4 2021. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Citadel Advisors held 1,878,048 shares of Clover Health Investments worth $3.31M as of Q1 2026.
  • Citadel Advisors bought 730,108 Clover Health Investments shares in Q1 2026, an estimated $1.58M.
  • Clover Health Investments made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5074 holding.
  • Citadel Advisors first reported a position in Clover Health Investments in Q4 2020 and has held it in 22 quarters since.
  • Citadel Advisors's Clover Health Investments position peaked at $13.4M in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.